Terbutaline Sulfate

硫酸特布他林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTerbutaline Sulfate
Drug Alias NameTerbutaline特布他林硫酸盐Terbutalinum硫酸叔丁肾上腺素间羟叔丁肾上腺素 +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsEmphysemaDiabetes Mellitus, Type 1Pulmonary Disease, Chronic Obstructive +[6] 
Global Approved IndicationsEmphysemaPulmonary Disease, Chronic ObstructiveBronchial Spasm +[5] 
Approved Indications in ChinaEmphysemaBronchial SpasmAsthma +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1974/03/25
Country/TerritoryCanadaUnited StatesSweden +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceutical Co Ltd
Inactive CompaniesJaeb Center For Health Research IncAstrazeneca PlcSanofi-Aventis U.S. Llc
Active IndicationsEmphysemaBronchial SpasmAsthma +[4] 
Inactive IndicationsDiabetes Mellitus, Type 1Pulmonary Disease, Chronic Obstructive

Other Information

ATC CodeR03AC03R03CC03
Related LinksWikipediaDrugBankKEGG